Weight loss, Lower Risk

There are several potential challengers to Novo Nordisk and Eli Lilly’s obesity drugs, and Jefferies analysts see one as ...
The diabetes startup is prescribing GLP-1 drugs for weight loss to help employers manage costs. Its CEO says it's nearing ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...
"All these years I thought that thin people -- those people -- just had more willpower," Winfrey said on her podcast.